Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 789

Showing 76-100 of 789 citing articles:

Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Chien‐Tai Hong, Jia‐Hung Chen, Chaur‐Jong Hu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10
Trends and hotspots in non-motor symptoms of Parkinson’s disease: a 10-year bibliometric analysis
Xuefeng Li, Chunhai Chen, Ting Pan, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 9
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
B Whittle, Osagie Izuogu, Hannah Lowes, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
Emmanouela Leandrou, Ioanna Chalatsa, Dimitrios Anagnostou, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
Pusheng Quan, Xueying Li, Yao Si, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses
Tae Yoon Park, Jeha Jeon, Young Cha, et al.
Cell Research (2024) Vol. 34, Iss. 7, pp. 479-492
Open Access | Times Cited: 9
Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Systemic inflammation and risk of Parkinson’s disease: A prospective cohort study and genetic analysis
Chunyu Li, Bin Ke, Jianhai Chen, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 447-455
Closed Access | Times Cited: 8
Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and disease
Peter Kilfeather, Jia Hui Khoo, Katherina Wagner, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113784-113784
Open Access | Times Cited: 8
Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer
Aastha Kaushik, Somya Parashar, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102279-102279
Closed Access | Times Cited: 8
Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease
Simone Bido, Melania Nannoni, Sharon Muggeo, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 761
Closed Access | Times Cited: 8
Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines
Armin Bayati, Riham Ayoubi, Adriana Aguila, et al.
Nature Neuroscience (2024)
Closed Access | Times Cited: 8
Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
Zhen Zhang, Kun Niu, Taoying Huang, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Exosomes-encapsulated biomimetic polydopamine carbon dots with dual-targeting effect alleviate motor and non-motor symptoms of Parkinson's disease via anti-neuroinflammation
Chen Die Yang, Yanhao Song, Mingkai Luo, et al.
International Journal of Biological Macromolecules (2025) Vol. 296, pp. 139724-139724
Closed Access | Times Cited: 1
Lewy body diseases and the gut
Timothy R. Sampson, Malú G. Tansey, Andrew B. West, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses
Thuy-vi Nguyen, Shristi Khanal, Eun-Hee Lee, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers
Yi‐Han Gan, Lingzhi Ma, Yi Zhang, et al.
Nature Aging (2025)
Closed Access | Times Cited: 1
The relationship between telomere length and aging-related diseases
Xiaoqin Huang, Leyi Huang, Jiameng Lu, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: insights from non-human primate studies
Marina E. Emborg, Jeanette M. Metzger, Kevin A. D’Amour, et al.
Brain Research Bulletin (2025), pp. 111297-111297
Open Access | Times Cited: 1
A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models
Chiara Pavan, Kathryn C. Davidson, Natalie L. Payne, et al.
Cell stem cell (2025)
Open Access | Times Cited: 1
Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson’s Disease
Gregory P. Williams, Aubrey M. Schonhoff, Alessandro Sette, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S129-S136
Open Access | Times Cited: 33
Paraquat exposure induces Parkinsonism by altering lipid profile and evoking neuroinflammation in the midbrain
Tong Tong, Weixia Duan, Yu‐Dong Xu, et al.
Environment International (2022) Vol. 169, pp. 107512-107512
Open Access | Times Cited: 33
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 162-177
Closed Access | Times Cited: 33
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Luca Soraci, Maria Elsa Gambuzza, Leonardo Biscetti, et al.
Journal of Neurology (2022) Vol. 270, Iss. 3, pp. 1346-1360
Open Access | Times Cited: 30
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Shiqing Nie, Jichen Wang, Ye Deng, et al.
npj Biofilms and Microbiomes (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30

Scroll to top